For: | Hammer L, Furtado S, Mathiowitz E, Auci DL. Oral encapsulated transforming growth factor β1 reduces endogenous levels: Effect on inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2020; 11(5): 79-92 [PMID: 33251033 DOI: 10.4292/wjgpt.v11.i5.79] |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v11/i5/79.htm |
Number | Citing Articles |
1 |
Margaret Bohmer, Yonger Xue, Katarina Jankovic, Yizhou Dong. Advances in engineering and delivery strategies for cytokine immunotherapy. Expert Opinion on Drug Delivery 2023; 20(5): 579 doi: 10.1080/17425247.2023.2208344
|
2 |
Ye Liu, Jinjian Huang, Sicheng Li, Ze Li, Canwen Chen, Guiwen Qu, Kang Chen, Yitian Teng, Rui Ma, Xiuwen Wu, Jianan Ren. Advancements in hydrogel-based drug delivery systems for the treatment of inflammatory bowel disease: a review. Biomaterials Science 2024; 12(4): 837 doi: 10.1039/D3BM01645E
|
3 |
Nasim Hatamzade Esfahani, Andrew S. Day. The Role of TGF-β, Activin and Follistatin in Inflammatory Bowel Disease. Gastrointestinal Disorders 2023; 5(2): 167 doi: 10.3390/gidisord5020015
|
4 |
Ferdinando Nicoletti, Laura Hammer, Stacia Furtado, Katia Mangano, Edith Mathiowitz, Benjamin Green, Dominick L Auci. Oral Delivery of Encapsulated All-Trans Retinoic Acid Ameliorates Disease in Rodent Models of Colitis. Inflammatory Bowel Diseases 2022; 28(3): 455 doi: 10.1093/ibd/izab204
|